Oliver Schnell Selected Research

Nitrogen-13

12/2002	Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus.
7/2002	Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Schnell Research Topics

Disease

30	Type 2 Diabetes Mellitus (MODY) 10/2022 - 12/2002
27	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 12/2007
26	Neoplasms (Cancer) 07/2022 - 07/2006
20	Glioma (Gliomas) 08/2022 - 06/2006
13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 07/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2005
9	Heart Failure 01/2022 - 09/2013
6	Hyperglycemia 01/2020 - 11/2008
6	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 11/2011
5	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2010
5	Myocardial Infarction 12/2019 - 12/2007
4	Meningioma (Meningiomas) 04/2022 - 01/2018
4	COVID-19 01/2022 - 01/2020
4	Weight Gain 03/2020 - 06/2009
4	Diabetes Mellitus 12/2016 - 07/2002
3	Hypoxia (Hypoxemia) 01/2018 - 01/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 05/2015
3	Diabetes Complications 05/2014 - 10/2009
2	Astrocytoma (Pilocytic Astrocytoma) 05/2022 - 07/2011
2	Disease Progression 05/2022 - 09/2014
2	Oligodendroglioma 05/2022 - 07/2011
2	Overweight 01/2022 - 01/2022
2	Weight Loss (Weight Reduction) 01/2022 - 10/2020
2	Insulin Resistance 01/2022 - 01/2017
2	Residual Neoplasm 01/2022 - 03/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2021 - 01/2020
2	Body Weight (Weight, Body) 04/2020 - 05/2016
2	Death (Near-Death Experience) 01/2020 - 09/2013
2	Fibrosis (Cirrhosis) 09/2019 - 07/2012
2	Inflammation (Inflammations) 09/2019 - 08/2004
2	Glucose Intolerance 04/2014 - 09/2013
2	Coronary Disease (Coronary Heart Disease) 04/2014 - 09/2013
2	Acute Coronary Syndrome 01/2006 - 12/2005
1	Brain Abscess (Abscess, Brain) 03/2022
1	Suppuration 03/2022
1	Neurologic Manifestations (Neurological Manifestations) 03/2022
1	Peripheral Arterial Disease 02/2022

Drug/Important Bio-Agent (IBA)

25	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 12/2005
24	Insulin (Novolin)FDA Link 05/2022 - 12/2002
14	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2007
10	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 07/2012
7	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
6	Pharmaceutical PreparationsIBA 01/2022 - 11/2011
6	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2020
6	Hypoglycemic Agents (Hypoglycemics)IBA 06/2016 - 11/2008
5	Biomarkers (Surrogate Marker)IBA 05/2021 - 07/2011
5	Acarbose FDA LinkGeneric 05/2016 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2007
4	IntegrinsIBA 06/2018 - 07/2008
4	C-Reactive ProteinIBA 07/2013 - 08/2004
3	Peptides (Polypeptides)IBA 05/2022 - 07/2008
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2022 - 07/2011
3	Lomustine (CCNU)FDA Link 01/2022 - 01/2019
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 07/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2020 - 12/2014
3	CytokinesIBA 11/2019 - 01/2019
3	MethyltransferasesIBA 01/2018 - 12/2007
3	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2016
3	Biological ProductsIBA 02/2014 - 04/2011
2	Immune Checkpoint InhibitorsIBA 05/2022 - 02/2019
2	B7-H1 AntigenIBA 05/2022 - 09/2017
2	Protein Subunit VaccinesIBA 05/2022 - 01/2021
2	LDL CholesterolIBA 02/2022 - 01/2017
2	Meclofenamic Acid (Meclofenamate)FDA LinkGeneric 01/2022 - 11/2021
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2019
2	SodiumIBA 10/2020 - 07/2014
2	Pioglitazone (Actos)FDA Link 01/2020 - 06/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 12/2014
2	RNA (Ribonucleic Acid)IBA 11/2019 - 02/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 10/2016
2	Epidermal Growth Factor (EGF)IBA 02/2017 - 03/2015
2	Glycoside Hydrolase InhibitorsIBA 05/2016 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 12/2007
2	Alkylating AgentsIBA 09/2012 - 12/2007
2	Integrin beta3 (GPIIIa)IBA 12/2009 - 07/2008
2	Integrin alphaVbeta3IBA 12/2009 - 07/2008
2	Hemoglobins (Hemoglobin)IBA 10/2009 - 11/2008
2	Nitrogen-13IBA 12/2002 - 07/2002
2	AmmoniaIBA 12/2002 - 07/2002
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2002 - 07/2002
1	Peptide Hydrolases (Proteases)FDA Link 07/2022
1	CalpainIBA 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	ElementsIBA 01/2022
1	C-PeptideIBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 11/2021
1	CreatinineIBA 10/2021

Therapy/Procedure

39	Therapeutics 05/2022 - 08/2004
14	Radiotherapy 08/2022 - 04/2011
12	Drug Therapy (Chemotherapy) 08/2022 - 07/2011
10	Glycemic Control 01/2020 - 06/2009
5	Chemoradiotherapy 05/2020 - 09/2014
4	Immunotherapy 05/2022 - 06/2017
3	Re-Irradiation 01/2022 - 12/2012
3	Contraindications 10/2020 - 12/2012
2	Palliative Care (Palliative Therapy) 01/2020 - 09/2013
2	Adjuvant Radiotherapy 11/2019 - 01/2018
1	Obesity Management 01/2022